Oryzon Genomics (STU:ORN) Accounts Payable : €0.00 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Oryzon Genomics Accounts Payable?

Oryzon Genomics's Accounts Payable for the quarter that ended in Mar. 2024 was €0.00 Mil.

Oryzon Genomics's quarterly Accounts Payable increased from Sep. 2023 (€3.15 Mil) to Dec. 2023 (€3.46 Mil) but then declined from Dec. 2023 (€3.46 Mil) to Mar. 2024 (€0.00 Mil).

Oryzon Genomics's annual Accounts Payable increased from Dec. 2021 (€2.92 Mil) to Dec. 2022 (€5.13 Mil) but then declined from Dec. 2022 (€5.13 Mil) to Dec. 2023 (€3.46 Mil).

Oryzon Genomics Accounts Payable Historical Data

The historical data trend for Oryzon Genomics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oryzon Genomics Accounts Payable Chart

Oryzon Genomics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

3.29

2.03

2.92

5.13

3.46

Oryzon Genomics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial															3.00	3.28	3.15	3.46	-

Oryzon Genomics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Oryzon Genomics Accounts Payable Related Terms

Thank you for viewing the detailed overview of Oryzon Genomics's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Oryzon Genomics (STU:ORN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oryzon Genomics SA (STU:ORN) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

ORYZF:USA ORY:Spain

Address

Sant Ferran 74, Cornellà de Llobregat, Barcelona, ESP, 08940

Website

http://www.oryzon.com

Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.